Skip to content
  • About
    • Statutes & Bylaws
    • Membership application
    • Expert Clinical Center application
    • Centers
      • Porphyria centres
      • Endorsed Porphyria Expert Clinical Centers
    • Executive Board
    • General Assemblies
    • Working Groups
    • Patient organizations
    • Honorary Members
    • Corporate members
  • Patients
    • Introduction to porphyria
    • Acute porphyria
    • Drugs and acute hepatic porphyrias
    • Acute porphyria – diagnosis – FAQ
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic Protoporphyrias (EPP & XLP)
    • Congenital erythropoietic porphyria (CEP)
    • Skin Protection in Cutaneous Porphyria
  • Professionals
    • The porphyrias
    • Laboratory diagnosis
    • Investigating the family
    • Treatment of the acute attack
    • Drugs and acute hepatic porphyrias
    • Help for Clinicians
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic protoporphyria (EPP & XLEPP)
  • News
  • Events
  • About
    • Statutes & Bylaws
    • Membership application
    • Expert Clinical Center application
    • Centers
      • Porphyria centres
      • Endorsed Porphyria Expert Clinical Centers
    • Executive Board
    • General Assemblies
    • Working Groups
    • Patient organizations
    • Honorary Members
    • Corporate members
  • Patients
    • Introduction to porphyria
    • Acute porphyria
    • Drugs and acute hepatic porphyrias
    • Acute porphyria – diagnosis – FAQ
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic Protoporphyrias (EPP & XLP)
    • Congenital erythropoietic porphyria (CEP)
    • Skin Protection in Cutaneous Porphyria
  • Professionals
    • The porphyrias
    • Laboratory diagnosis
    • Investigating the family
    • Treatment of the acute attack
    • Drugs and acute hepatic porphyrias
    • Help for Clinicians
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic protoporphyria (EPP & XLEPP)
  • News
  • Events
Read more about the article Help for Clinicians

Help for Clinicians

  • Post author:Tobias Zimmermann
  • Post published:14 July, 2025
  • Post category:Allgemein
  • Post comments:0 Comments

Refer a patient:We offer support to clinicians looking after patients with suspected or confirmed porphyria in countries where expert advice is not available. We can help with laboratory testing, interpretation…

Continue ReadingHelp for Clinicians
Read more about the article ICPP 2024 Pamplona

ICPP 2024 Pamplona

  • Post author:Tobias Zimmermann
  • Post published:14 September, 2024
  • Post category:Allgemein
  • Post comments:0 Comments

The International Congress of Porphyrins and Porphyrias took place on September 21-25, 2024 in Pamplona, Spain, bringing together clinicians, researchers, scholars, patients and their families for three days networking and…

Continue ReadingICPP 2024 Pamplona
Read more about the article IPNET newsletter, june 2024

IPNET newsletter, june 2024

  • Post author:Tobias Zimmermann
  • Post published:14 June, 2024
  • Post category:Allgemein
  • Post comments:0 Comments

Dear all Ipnet members, It is a great pleasure again to publish the new issue of the Ipnet Newsletter.A warm thank you to Nica Cappellini and her team for all this…

Continue ReadingIPNET newsletter, june 2024
Read more about the article IPNET newsletter, january 2024

IPNET newsletter, january 2024

  • Post author:Tobias Zimmermann
  • Post published:14 January, 2024
  • Post category:Allgemein
  • Post comments:0 Comments

Dear all Ipnet members, It is a great pleasure for Ipnet to circulate the first issue of the Ipnet Newsletter.A warm thank you to Nica Cappellini and her co-editors for all…

Continue ReadingIPNET newsletter, january 2024
Read more about the article Key terms and definitions in acute porphyrias

Key terms and definitions in acute porphyrias

  • Post author:Tobias Zimmermann
  • Post published:1 January, 2024
  • Post category:Allgemein
  • Post comments:0 Comments

Dear colleagues and friends, We are very happy to inform you that the paper “Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the…

Continue ReadingKey terms and definitions in acute porphyrias

Neueste Beiträge

  • IPNET newsletter, december 2025
  • Help for Clinicians
  • ICPP 2024 Pamplona
  • IPNET newsletter, june 2024
  • IPNET newsletter, january 2024

Neueste Kommentare

No comments to show.

An international network of experts working together to improve healthcare services for porphyria patients

International Porphyria Network

Postal adress

c/o studio12 gmbh
Kaiser-Josef-Straße 9
6020 Innsbruck, Austria

Email: office@ipnet.org
Phone: +43 512 89043 600

Registered adress

NAPOS, Department of Medical Biochemistry and Pharmacology (MBF)
Haukeland Universitetssykehus, P.O. Box 1400
5021 Bergen, Norway

Email: office@ipnet.org
Phone: +43 512 89043 600

© 2026 IPNET - all rights reserved

Disclaimer | Privacy Policy | Cookie Policy
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}